Clemens, Vera
Köhler-Dauner, Franziska
Keller, Ferdinand
Ziegenhain, Ute
Fegert, Jörg M.
Funding for this research was provided by:
Universität Ulm
Article History
Received: 18 October 2021
Accepted: 21 June 2022
First Online: 11 August 2022
Declarations
:
: Electronic informed consent was obtained from each participant prior to starting the survey. Information on the study and data analysis were given. Participation was voluntary and anonymous. Participants could withdraw from the survey at any moment without providing any justification. The study was conducted in accordance with the Declaration of Helsinki. After consultation with the ethics committee of the University of Ulm, the committee officially stated that there is no requirement for an ethics vote due to the anonymous character of the study: <i>“I can now inform you that no ethics application is necessary for this. We will therefore not make a substantive statement or evaluation from the point of view of professional law or ethics. A file number will not be assigned. This e-mail complies with the written form as defined in § 126 para. 3 BGB (German Civil Code). You can use it as proof in the event of any enquiries by for an ethics vote by scientific journals, authorities or third-party funders.”</i>
: Not applicable.
: VC, FK, FKD and UZ declare that they have no competing interests.JMF has received research funding from the EU, DFG (German Research Foundation), BMG (Federal Ministry of Health), BMBF (Federal Ministry of Education and Research), BMFSFJ (Federal Ministry of Family, Senior Citizens, Women and Youth), G-BA Innovationsfonds, several state ministries, State Foundation Baden-Württemberg, Volkswagen Foundation, Porticus Foundation, Diocese of Rottenburg-Stuttgart. Moreover, he received travel grants, honoraria and sponsoring for conferences and medical educational purposes from APK, Deutschlandfunk, DFG, DJI, DKSB, Infectopharm, med update, UNICEF, several universities, professional associations, political foundations, and German federal and state ministries during the last 5 years. Professor Fegert holds no stocks of pharmaceutical companies.